With You in the Fight Against RHDV2
We know rabbit owners love their rabbit just as much as any other pet owner loves theirs. Our love for pets is what drove us to develop our vaccine for RHDV2. Medgene Labs' vaccine is available now under Emergency Use Authorization from the USDA; a list of states where we are approved to distribute can be found below.
Help us in the fight against RHDV2.
Frequently Asked Questions
Medgene Labs is actively engaged with state veterinarians to work through each state's requirements for distribution and reporting. We have currently completed the process with 45 state veterinarians as well as Washington DC. Below is a list of the states we are able to distribute RHDV2 vaccines to. We continue to work diligently to make this vaccine available nationwide to do our part in stopping this pandemic. This list will be updated as additional states are approved.
Connecticut (approval on individual basis)
Florida (approval on individual basis)
Montana (approval on individual basis)
Tennessee (approval on individual basis)
Rabbit Hemorrhagic Disease Review
Rabbit hemorrhagic disease is a highly contagious, fatal disease in rabbits and is currently classified as a reportable, foreign animal disease in the United States. Animal health officials detected rabbit hemorrhagic disease virus serotype 2 (RHDV2) for the third time in the United States in February 2020. It has since been spreading across the country. It is important to note that RHDV2 does not impact human health.
RHDV2, unlike other rabbit hemorrhagic disease viruses, affects both domestic and wild rabbits. Infected rabbits may develop a fever, be hesitant to eat, or show respiratory or nervous signs. However, many times, the only signs of the disease are sudden death.
How RHDV2 Spreads
RHDV2 can be spread through direct contact or exposure to an infected rabbit’s excretions or blood. The virus can also survive and be spread from carcasses, food, water, and any contaminated materials. It has also been spread by insects. Because of survivability, people can spread the virus indirectly by carrying it on their clothing and shoes after being exposed to an infected animal or environment. Thorough biosecurity and vaccination are the only way to protect your rabbits.
Summary of Efficacy Study
A study was performed to evaluate the vaccine’s performance against direct challenge with live RHDV2 virus. The study results in Table 1 (below) showed zero mortalities in the vaccinated group of rabbits and a 69% mortality rate in the placebo group after being challenged with the RHDV2 virus. The difference in mortality rates between the vaccinated and placebo groups was highly statistically significant with a p-value of 0.0017.
Challenge Study Results
|Treatment Group 1 (Placebo)||69%|
|Treatment Group 2 (Vaccinates)||0%|
Safety Study Data
All safety studies have been completed and are under review by the CVB. Updates will be provided as soon as the studies have been approved.
Prior to receieving approval by the USDA for Emergency Use Authorization, 105 rabbits (kits and breeding stock in various stages of reproduction) were fully vaccinated and observed for safety concerns. Of these 105 rabbits, one kit and one adult rabbit exhibited minor post injection swelling at the site of administration. This swelling was resolved within 48 hours.
We ship Monday - Wednesday via overnight carrier.
To be eligible for same week shipping, we need to receive all completed paperwork by 1 pm, Central Time, on Tuesday.
For more information, the items below are available for you to download.